
ASCE+ HRLV-E is an ExoCoBio professional scalp-care product whose published U.S. label describes a lyophilized, biotin-containing formula with Rosa damascena callus extracellular vesicles for external use.
The brand positions HRLV as a premium hair and scalp solution, but product-specific independent clinical evidence remains limited and exosome terminology does not establish an approved treatment for hair-loss disease. Clinics should separate label facts from broader regenerative-aesthetics claims.
Catalogue visual: ASCE+ HRLV-E ( Scalp Care ) from the NEES Medical product catalogue. Packaging appearance alone does not establish authenticity; verify the supplied batch, expiry, seals and traceability documents.
ASCE+ HRLV-E belongs to ExoCoBio's professional ASCE+ range. DailyMed lists EXOSCRT Scalp Care HRLV as a topical biotin powder and identifies Rosa damascena callus extracellular vesicles among the inactive ingredients; the label purpose is scalp care and the warnings specify external use only.
DailyMed also states that this listing has not been found by the FDA to be safe and effective and that its labeling has not been approved by FDA. That distinction is essential: an NDC or DailyMed record is not equivalent to product approval. Any local use should follow Pakistan requirements and the exact supplied label.
HRLV sits in the professional topical scalp-care and regenerative-aesthetics segment. It should not be presented as a direct replacement for a medical diagnosis or for evidence-based treatment of androgenetic alopecia or another defined hair disorder.
| Option | Primary role | Evidence and buying distinction |
|---|---|---|
| ASCE+ HRLV-E | Manufacturer-positioned professional topical scalp-care product with lyophilized powder. | Verify external-use label, cold storage, kit integrity and ExoCoBio identifiers; product-specific independent trials are limited. |
| Evidence-based hair-loss medicines | Condition-specific medical management selected after diagnosis. | Approval, eligibility, contraindications and expected outcomes are medicine- and patient-specific. |
| Platelet-rich plasma | Autologous procedure used by some clinics for selected hair-loss presentations. | Evidence and protocols vary, and it is a procedure rather than a packaged topical product. |
| General scalp cosmeceuticals | Cleansing, conditioning or cosmetic scalp support. | Usually less complex to procure but should not be promoted as treating diagnosed alopecia without evidence and authorization. |
ASCE+ HRLV-E Scalp Care pricing in Pakistan requires a current quotation. A useful clinic quote should state stock status, exact kit presentation, batch, expiry, cold-chain terms and delivery coverage.
NEES Medical lists the product for professional inquiry, but clinics should not compare a refrigerated, traceable kit with an unverified marketplace listing on price alone.
View the ASCE+ HRLV-E ( Scalp Care ) catalogue page or request current pricing and availability.
What is the ASCE+ HRLV-E price in Pakistan?
A quotation is required because stock, expiry and temperature-controlled delivery can change. Ask for the exact HRLV-E presentation and the documentation included with the quote.
Is ASCE+ HRLV-E an FDA-approved hair-loss treatment?
No such claim should be made. Its DailyMed page says the product has not been found by FDA to be safe and effective and that the labeling has not been FDA-approved.
How can a clinic verify genuine ASCE+ HRLV-E?
Match the kit to official ExoCoBio and DailyMed information, inspect batch and expiry details, retain the invoice and cold-chain record, and verify questionable authentication codes or packaging through an official ExoCoBio channel.
How should ASCE+ HRLV-E be stored and what is its shelf life?
The published DailyMed label states 2–8°C storage. The usable shelf life is the expiry on the intact supplied kit; confirm that refrigeration was maintained throughout distribution.
When should a patient expect hair results?
There is no universal product-specific timeline established by strong independent evidence. Hair-cycle changes are slow and depend on diagnosis, baseline condition and the clinician's overall plan, so expectations should be set by a qualified practitioner.
Can ASCE+ HRLV-E be injected?
The cited DailyMed label states external use only. This guide does not support injection or any use that conflicts with the exact market-specific label.